Rifapentine access in Europe: growing concerns over key tuberculosis treatment component. Guglielmetti L, Gunther G, Leu C, Cirillo D, et al. Eur Respir J 2022;59.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Guglielmetti L, Gunther G, Leu C, Cirillo D, et al. Rifapentine access in Europe: growing concerns over key tuberculosis treatment component. Eur Respir J 2022;59.
PMID: 35589114